Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Corbett

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activityB J Foster, R A Wiegand, S Pugh, et al.
Journal of Medicinal Chemistry|November 2, 2001
Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activityR Wang, M B Ksebati, T H Corbett, et al.
Cancer Research|March 1, 1988
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivoM C Bissery, F A Valeriote, G G Chabot, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasmaS Poondru, S Zhou, J Rake, et al.
Cancer Research|May 1, 1982
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755)T H Corbett, W R Leopold, D J Dykes, et al.
Anesthesia and Analgesia|November 1, 1978
A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in miceE I Eger, A E White, C L Brown, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1985
DNA binding, cardiac superoxide production and cytotoxicity of daunomycin analogsJ P Nachtman, E T Roginski, J W Banning, et al.
Cancer Treatment Reports|October 1, 1983
Establishment of cross-resistance profiles for new agentsF M Schabel, H E Skipper, M W Trader, et al.
Investigational New Drugs|November 1, 1989
Activity of batracylin (NSC-320846) against solid tumors of miceP Mucci-LoRusso, L Polin, M C Bissery, et al.
Cancer Treatment Reports|May 1, 1982
Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agentsT H Corbett, B J Roberts, M W Trader, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activityB J Foster, R A Wiegand, S Pugh, et al.
Journal of Medicinal Chemistry|November 2, 2001
Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activityR Wang, M B Ksebati, T H Corbett, et al.
Cancer Research|March 1, 1988
Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivoM C Bissery, F A Valeriote, G G Chabot, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|August 14, 2001
High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasmaS Poondru, S Zhou, J Rake, et al.
Cancer Research|May 1, 1982
Toxicity and anticancer activity of a new triazine antifolate (NSC 127755)T H Corbett, W R Leopold, D J Dykes, et al.
Anesthesia and Analgesia|November 1, 1978
A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in miceE I Eger, A E White, C L Brown, et al.
Research Communications in Chemical Pathology and Pharmacology|January 1, 1985
DNA binding, cardiac superoxide production and cytotoxicity of daunomycin analogsJ P Nachtman, E T Roginski, J W Banning, et al.
Cancer Treatment Reports|October 1, 1983
Establishment of cross-resistance profiles for new agentsF M Schabel, H E Skipper, M W Trader, et al.
Investigational New Drugs|November 1, 1989
Activity of batracylin (NSC-320846) against solid tumors of miceP Mucci-LoRusso, L Polin, M C Bissery, et al.
Cancer Treatment Reports|May 1, 1982
Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agentsT H Corbett, B J Roberts, M W Trader, et al.
Pageof 10